Literature DB >> 16652107

Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis.

Seung-Beom Hong1, Mutsuo Furihata, Masaya Baba, Berton Zbar, Laura S Schmidt.   

Abstract

Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene leads to the development of central nervous system hemangioblastomas, pheochromocytomas and renal cell carcinomas. The biological role of the VHL gene during development is poorly understood because of early lethality of VHL-null embryos. To overcome early embryo lethality observed in the conventional knockout mouse, we introduced a tamoxifen-inducible Cre (CreER(TM)) transgene for the stage specific inactivation of the VHL gene. Acute tamoxifen-induced inactivation of the VHL gene at E10.5 resulted in embryonic lethality between E14.5 and E15.0 with extensive hemorrhage and necrosis, while littermate controls showed normal development. Examination of the VHL-inactivated embryos between E10.5 and E14.5 revealed dilated blood vessels, hemorrhage and necrotizing liver damage. Concomitant with severe hemorrhage and abnormal vasculature at E15.0, blood circulation in the yolk sac was impaired in the VHL-inactivated embryos, which may be the cause of embryo death. Placental development looked normal before embryo death (E14.5); however, at E16.5 following embryo death, we observed reduced growth of the placental labyrinthine layer. Inactivation of the VHL gene resulted in hypoxia-inducible factor (HIF)-1alpha stabilization and induction of its target genes, VEGF and CAIX, in mouse embryonic fibroblasts (MEFs). In addition, we observed lactate overproduction and acidification of culture media by the inactivation of the VHL gene. Thus, by using a novel conditional VHL knockout mouse model, we could show that the VHL gene plays an important role in the developing vasculature and liver during embryogenesis through regulation of HIF-1alpha and its target genes. This mouse model will be useful for the screening of anti-HIF or anti-VEGF drugs in vivo. Additionally, this acute VHL inactivation system may provide a useful tool for the in vivo study of genes that cause early embryonic lethality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652107     DOI: 10.1038/labinvest.3700431

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice.

Authors:  Bart van de Sluis; Patricia Muller; Karen Duran; Amy Chen; Arjan J Groot; Leo W Klomp; Paul P Liu; Cisca Wijmenga
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

2.  Histology Atlas of the Developing Mouse Hepatobiliary Hemolymphatic Vascular System with Emphasis on Embryonic Days 11.5-18.5 and Early Postnatal Development.

Authors:  Olivia M Swartley; Julie F Foley; David P Livingston; John M Cullen; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2016-03-08       Impact factor: 1.902

3.  Increased expression of the von Hippel-Lindau gene in the implantation site of human tubal pregnancy.

Authors:  Jian-Ying Xu; Wei-Jie Zhu; Huan Jiang
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

4.  Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Mitsuko Iguchi; Yoshihiko Kakinuma; Atsushi Kurabayashi; Takayuki Sato; Taro Shuin; Seung-Beom Hong; Laura S Schmidt; Mutsuo Furihata
Journal:  Nephron Exp Nephrol       Date:  2008-10-27

5.  Development of a chromosomally integrated metabolite-inducible Leu3p-alpha-IPM "off-on" gene switch.

Authors:  Maria Poulou; Donald Bell; Kostas Bozonelos; Maria Alexiou; Anthony Gavalas; Robin Lovell-Badge; Eumorphia Remboutsika
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

6.  The VHL-dependent regulation of microRNAs in renal cancer.

Authors:  Calida S Neal; Michael Z Michael; Lesley H Rawlings; Mark B Van der Hoek; Jonathan M Gleadle
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

Review 7.  The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Authors:  P P Kapitsinou; V H Haase
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

8.  JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.

Authors:  Dongyun Zhang; Jingxia Li; Max Costa; Jimin Gao; Chuanshu Huang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

9.  Inactivating the spindle checkpoint kinase Bub1 during embryonic development results in a global shutdown of proliferation.

Authors:  Valerie Tilston; Stephen S Taylor; David Perera
Journal:  BMC Res Notes       Date:  2009-09-23

10.  Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.

Authors:  H-C Jennifer Shen; Asha Adem; Kris Ylaya; Arianne Wilson; Mei He; Dominique Lorang; Stephen M Hewitt; Klaus Pechhold; David M Harlan; Irina A Lubensky; Laura S Schmidt; W Marston Linehan; Steven K Libutti
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.